Novartis

Novartis is a global healthcare company headquartered in Basel, Switzerland, that provides innovative medicines to patients worldwide. The company focuses on four core therapeutic areas: immunology, neuroscience, oncology, and hematology. Novartis has a rich history of pharmaceutical breakthroughs, including the development of Gleevec for chronic myeloid leukemia, which transformed the disease from a fatal condition to a manageable one. The company's portfolio includes treatments for conditions ranging from heart failure and macular degeneration to breast cancer and multiple sclerosis. Novartis invests approximately 20 percent of its revenue in research and development each year, maintaining a robust pipeline of potential new medicines across various stages of clinical testing.